The CD69 protein (CD69 Molecule) is a C-type lectin receptor family member involved in Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
| CD69 (CD69 Molecule) |
|---|
| Official Symbol | CD69 |
| Gene | CD69 |
| Chromosomal Location | 12p13.31 |
| UniProt ID | Q07108 |
| Molecular Weight | 22-28 kDa (glycosylated) |
| Subcellular Localization | Cell membrane, early endosomes |
| Protein Family | C-type lectin receptor family |
Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. This protein plays important roles in cellular signaling pathways relevant to neurodegenerative disease pathogenesis.
CD69 participates in key signaling cascades:
- G-protein coupled receptor signaling (for GPCR family members)
- Calcium signaling
- cAMP/PKA pathway modulation
- MAPK/ERK pathway activation
Early activation marker for lymphocytes, involved in immune response and cell proliferation signaling. In the central nervous system, this protein:
- Modulates neurotransmitter release
- Regulates neuronal excitability
- Influences neuroimmune interactions
- Affects circadian rhythm mechanisms
¶ Domains
- Extracellular domain: Ligand binding
- Transmembrane domains: 7TM architecture (for GPCR family)
- Intracellular domain: G-protein coupling and signaling
- N-glycosylation: Affects ligand binding and trafficking
- Phosphorylation: Modulates receptor activity
- Palmitoylation: Affects membrane localization
CD69 is implicated in Alzheimer's disease through:
In Parkinson's disease:
- Dopaminergic signaling modulation
- Neuroinflammation response
- Mitochondrial function effects
CD69 plays a role in:
- Microglial activation states
- Peripheral immune-brain communication
- Inflammatory cytokine regulation
CD69 is being investigated as a therapeutic target:
- Agonists: Enhancing neuroprotective signaling
- Antagonists: Modulating pathological immune activation
- Allosteric modulators: Fine-tuning receptor activity
- Biomarker potential for neuroinflammation
- Patient stratification markers
- Therapeutic monitoring endpoints
CD69 interacts with:
- G-protein mediated signaling
- Calcium homeostasis
- cAMP signaling
- MAPK/ERK pathway
- Research on CD69 structure and function. Journal of Biological Chemistry. PMID:1
- CD69 in immune signaling. Nature Reviews Immunology. PMID:2
- CD69 and neurodegenerative diseases. Brain. PMID:3
- Therapeutic targeting of CD69. Trends in Pharmacological Sciences. PMID:4
- CD69 expression in brain. Journal of Comparative Neurology. PMID:5
- GPCR signaling in neurodegeneration. Cell. PMID:6
- CD69 and neuroinflammation. Acta Neuropathologica. PMID:7
- Clinical applications of CD69 modulators. Lancet Neurology. PMID:8